Tag: Spike Glycoprotein
Variant-Proof SARS-CoV-2 Vaccine: a CEPI-funded ExcellGene partnership with Bharat Biotech &...
An entirely new “chimeric” spike antigen complex, different from any protein of existing SARS-CoV-2 variants, will be generated